Latest News and Press Releases
Want to stay updated on the latest news?
-
Q1 2025 pharma services revenue of $2.1 million, at 62% gross marginThree of the top 10 U.S. transplant centers expected to participate in clinical trialTen globally leading transplant hospitals are...
-
Oncocyte to Release First Quarter 2025 Results on May 12, 2025
-
Central Institutional Review Board approved, final preparatory steps underway at first transplant centersThree of the top 10 U.S. transplant centers expected to participate in trialNearly 10% of...
-
Robust data set of 131 patients with 151 kidney biopsies enrolled over four years at Charité University in BerlinSupports market expansion for testing of high-risk patient populationNew findings...
-
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
-
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
-
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
-
Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
-
Oncocyte Prices $29.1 Million Equity Offering
-
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer